Andrea E Wahner Hendrickson, MD

  • 849 Citations
  • 14 Scopus h-Index
19982019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1998 2019

  • 849 Citations
  • 14 Scopus h-Index
  • 30 Article
  • 2 Review article
2019
2 Citations (Scopus)

53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer

Hurley, R. M., Wahner Hendrickson, A. E., Visscher, D. W., Ansell, P., Harrell, M. I., Wagner, J. M., Negron, V., Goergen, K. M., Maurer, M. J., Oberg, A. L., Meng, X. W., Flatten, K. S., De Jonge, M. J. A., Van Herpen, C. D., Gietema, J. A., Koornstra, R. H. T., Jager, A., den Hollander, M. W., Dudley, M., Shepherd, S. P. & 2 others, Swisher, E. M. & Kaufmann, S. H., Jan 1 2019, (Accepted/In press) In : Gynecologic Oncology.

Research output: Contribution to journalArticle

Homologous Recombination
Ovarian Neoplasms
DNA End-Joining Repair
Neoplasms
Gene Deletion
1 Citation (Scopus)

Can Poly (ADP-Ribose) Polymerase Inhibitors Palliate Paclitaxel-Induced Peripheral Neuropathy in Patients With Cancer?

Balko, R. A., Wahner Hendrickson, A. E., Grudem, M. E., Klampe, C. M. & Jatoi, A., Jan 1 2019, In : American Journal of Hospice and Palliative Medicine. 36, 1, p. 72-75 4 p.

Research output: Contribution to journalArticle

Peripheral Nervous System Diseases
Paclitaxel
Pain
Neoplasms
Hypesthesia

Clinical Pearls in Oncology 2019

Wahner Hendrickson, A. E. & Bundrick, J. B., Jan 1 2019, In : Disease-a-Month.

Research output: Contribution to journalReview article

Loratadine for Paclitaxel-Induced Myalgias and Arthralgias

Smith, C., Wahner Hendrickson, A. E., Grudem, M., Klampe, C., Deering, E. & Jatoi, A., Jan 1 2019, (Accepted/In press) In : American Journal of Hospice and Palliative Medicine.

Research output: Contribution to journalArticle

Loratadine
Myalgia
Arthralgia
Paclitaxel
Confidence Intervals
9 Citations (Scopus)

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

Moore, K. N., Secord, A. A., Geller, M. A., Miller, D. S., Cloven, N., Fleming, G. F., Wahner Hendrickson, A. E., Azodi, M., DiSilvestro, P., Oza, A. M., Cristea, M., Berek, J. S., Chan, J. K., Rimel, B. J., Matei, D. E., Li, Y., Sun, K., Luptakova, K., Matulonis, U. A. & Monk, B. J., May 1 2019, In : The Lancet Oncology. 20, 5, p. 636-648 13 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Therapeutics
niraparib
Homologous Recombination
Platinum
2 Citations (Scopus)

Open-Label Clinical Trial of Niraparib Combined with Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer

Vinayak, S., Tolaney, S. M., Schwartzberg, L., Mita, M., McCann, G., Tan, A. R., Wahner Hendrickson, A. E., Forero, A., Anders, C., Wulf, G. M., Dillon, P., Lynce, F., Zarwan, C., Erban, J. K., Zhou, Y., Buerstatte, N., Graham, J. R., Arora, S., Dezube, B. J. & Telli, M. L., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Clinical Trials
Therapeutics
Disease-Free Survival
Safety
2018
9 Citations (Scopus)

A phase i clinical trial of the Poly(ADP-ribose) polymerase inhibitor veliparib and weekly topotecan in patients with solid tumors

Wahner Hendrickson, A. E., Menefee, M. E., Hartmann, L. C., Long, H. J., Northfelt, D. W., Reid, J. M., Boakye-Agyeman, F., Kayode, O., Flatten, K. S., Harrell, M. I., Swisher, E. M., Poirer, G. G., Satele, D., Allred, J., Lensing, J. L., Chen, A., Ji, J., Zang, Y., Erlichman, C., Haluska, P. & 1 others, Kaufmann, S. H., Feb 15 2018, In : Clinical Cancer Research. 24, 4, p. 744-752 9 p.

Research output: Contribution to journalArticle

Topotecan
Clinical Trials
Neoplasms
Maximum Tolerated Dose
Mutation
2 Citations (Scopus)

Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers

Gast, K. C., Viscuse, P. V., Nowsheen, S., Haddad, T. C., Mutter, R., Wahner Hendrickson, A. E., Couch, F. J. & Ruddy, K. J., Feb 1 2018, In : Current Treatment Options in Cardiovascular Medicine. 20, 2, 18.

Research output: Contribution to journalReview article

Mutation
Radiotherapy
Thorax
Guidelines
Drug Therapy
1 Citation (Scopus)
Weight Loss
Weight Gain
Neoplasms
Weights and Measures
Tomography
2017
1 Citation (Scopus)

Doubling Down on BRCA-Mutated Cancer

Wahner Hendrickson, A. E., Kaufmann, S. H. & Swisher, E. M., 2017, (Accepted/In press) In : Trends in Cancer.

Research output: Contribution to journalArticle

Tumor-Infiltrating Lymphocytes
Neoplasms
Immunotherapy
Breast Neoplasms
Drug Therapy
1 Citation (Scopus)
Ovarian Neoplasms
Breast Neoplasms
Mutation
9 Citations (Scopus)

Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers

Colon-Otero, G., Weroha, S. J., Foster, N. R., Haluska, P., Hou, X., Wahner Hendrickson, A. E., Jatoi, A., Block, M. S., Dinh, T. A., Robertson, M. W. & Copland, J. A. III., Jul 1 2017, In : Gynecologic Oncology. 146, 1, p. 64-68 5 p.

Research output: Contribution to journalArticle

letrozole
Estrogen Receptors
Ovarian Neoplasms
Heterografts
Neoplasms
2016
26 Citations (Scopus)

4EBP1/c-MYC/PUMA and NF-kB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells

Yun, S., Vincelette, N. D., Knorr, K. L. B., Almada, L. L., Schneider, P. A., Peterson, K. L., Flatten, K. S., Dai, H., Pratz, K. W., Hess, A. D., Smith, B. D., Karp, J. E., Wahner Hendrickson, A. E., Fernandez-Zapico, M. E. & Kaufmann, S. H., Jun 2 2016, In : Blood. 127, 22, p. 2711-2722 12 p.

Research output: Contribution to journalArticle

NF-kappa B
Sirolimus
Cytotoxicity
Lymphocytes
Growth
30 Citations (Scopus)

Targeting immune checkpoints in unresectable metastatic cutaneous melanoma: a systematic review and meta-analysis of anti-CTLA-4 and anti-PD-1 agents trials

Yun, S., Vincelette, N. D., Green, M. R., Wahner Hendrickson, A. E. & Abraham, I., Jul 1 2016, In : Cancer Medicine. 5, 7, p. 1481-1491 11 p.

Research output: Contribution to journalArticle

CTLA-4 Antigen
Meta-Analysis
Melanoma
Cell Death
Skin
2014
19 Citations (Scopus)

A Mixed-Methods Feasibility Trial of Protein Kinase C Iota Inhibition with Auranofin in Asymptomatic Ovarian Cancer Patients

Jatoi, A., Radecki Breitkopf, C., Foster, N. R., Block, M. S., Grudem, M., Wahner Hendrickson, A. E., Carlson, R. E., Barrette, B., Karlin, N. & Fields, A. P., Dec 6 2014, (Accepted/In press) In : Oncology (Switzerland). p. 208-213 6 p.

Research output: Contribution to journalArticle

Auranofin
Ovarian Neoplasms
Interviews
protein kinase C lambda
Feasibility Studies
9 Citations (Scopus)

Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic

Wahner Hendrickson, A. E., Hawthorne, K. M., Goode, E. L., Kalli, K. R., Goergen, K. M., Bakkum-Gamez, J. N., Cliby, W. A., Keeney, G., Visscher, D. W., Tarabishy, Y., Oberg, A. L., Hartmann, L. C. & Maurer, M. J., Dec 2 2014, (Accepted/In press) In : Gynecologic Oncology.

Research output: Contribution to journalArticle

Fallopian Tube Neoplasms
Recurrence
Survival
Platinum
Ascites
2013
84 Citations (Scopus)

ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status

Huntoon, C. J., Flatten, K. S., Wahner Hendrickson, A. E., Huehls, A. M., Sutor, S. L., Kaufmann, S. H. & Karnitz, L. M., Jun 15 2013, In : Cancer Research. 73, 12, p. 3683-3691 9 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
gemcitabine
Drug Therapy
Topotecan
Cisplatin
7 Citations (Scopus)

Phase i study of tanespimycin in combination with bortezomib in patients with advanced solid malignancies

Schenk, E., Wahner Hendrickson, A. E., Northfelt, D. W., Toft, D. O., Ames, M. M., Menefee, M., Satele, D., Qin, R. & Erlichman, C., Oct 2013, In : Investigational New Drugs. 31, 5, p. 1251-1256 6 p.

Research output: Contribution to journalArticle

tanespimycin
Maximum Tolerated Dose
Neoplasms
Hyponatremia
Atrioventricular Block
2012
15 Citations (Scopus)

A phase II study of gemcitabine in combination with tanespimycin in advanced epithelial ovarian and primary peritoneal carcinoma

Wahner Hendrickson, A. E., Oberg, A. L., Glaser, G., Camoriano, J. K., Peethambaram, P. P., Colon-Otero, G., Erlichman, C., Ivy, S. P., Kaufmann, S. H., Karnitz, L. M. & Haluska, P., Feb 2012, In : Gynecologic Oncology. 124, 2, p. 210-215 6 p.

Research output: Contribution to journalArticle

tanespimycin
gemcitabine
Carcinoma
Blood Cells
Neoplasms
71 Citations (Scopus)

Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies

Gupta, M., Wahner Hendrickson, A. E., Yun, S. S., Han, J. J., Schneider, P. A., Koh, B. D., Stenson, M. J., Wellik, L. E., Shing, J. C., Peterson, K. L., Flatten, K. S., Hess, A. D., Smith, B. D., Karp, J. E., Barr, S., Witzig, T. E. & Kaufmann, S. H., Jan 12 2012, In : Blood. 119, 2, p. 476-487 12 p.

Research output: Contribution to journalArticle

Puma
Sirolimus
Chemical activation
Apoptosis
Mantle-Cell Lymphoma
2011
Emergencies
Neoplasms
66 Citations (Scopus)

Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment

Lewis, M. A., Wahner Hendrickson, A. E. & Moynihan, T. J., Sep 2011, In : CA Cancer Journal for Clinicians. 61, 5, p. 287-314 28 p.

Research output: Contribution to journalArticle

Emergencies
Neoplasms
Leukostasis
Tumor Lysis Syndrome
Superior Vena Cava Syndrome
2010
1 Citation (Scopus)

Insulin receptor A and IGF-IR in AML - Response

Wahner Hendrickson, A. E., Haluska, P., Erlichman, C., Gottardis, M., Carboni, J. E., Karp, J. E. & Kaufmann, S. H., Sep 1 2010, In : Cancer Research. 70, 17, p. 7010 1 p.

Research output: Contribution to journalArticle

Insulin Receptor
41 Citations (Scopus)

Oncologic Emergencies

Behl, D., Wahner Hendrickson, A. E. & Moynihan, T. J., Jan 2010, In : Critical Care Clinics. 26, 1, p. 181-205 25 p.

Research output: Contribution to journalArticle

Emergencies
Neoplasms
Nervous System
Lymphoma
Leukemia
2009
37 Citations (Scopus)

Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: Effect of the dual-receptor inhibitor BMS-536924 in vitro

Wahner Hendrickson, A. E., Haluska, P., Schneider, P. A., Loegering, D. A., Peterson, K. L., Attar, R., Smith, B. D., Erlichman, C., Gottardis, M., Karp, J. E., Carboni, J. M. & Kaufmann, S. H., Oct 1 2009, In : Cancer Research. 69, 19, p. 7635-7643 9 p.

Research output: Contribution to journalArticle

Somatomedin Receptors
Insulin Receptor
Acute Myeloid Leukemia
Protein Isoforms
Cell Line
37 Citations (Scopus)

Resistance pathways relevant to insulin-like growth factor-1 receptor-targeted therapy

Wahner Hendrickson, A. E. & Haluska, P., Oct 2009, In : Current Opinion in Investigational Drugs. 10, 10, p. 1032-1040 9 p.

Research output: Contribution to journalArticle

Somatomedin Receptors
Somatomedins
Therapeutics
Protein-Tyrosine Kinases
Blocking Antibodies
2008
12 Citations (Scopus)

Anticancer therapy: Boosting the bang of Bim

Wahner Hendrickson, A. E., Xue, W. M. & Kaufmann, S. H., Nov 3 2008, In : Journal of Clinical Investigation. 118, 11, p. 3582-3584 3 p.

Research output: Contribution to journalArticle

Mitogen-Activated Protein Kinase Kinases
Proto-Oncogene Proteins B-raf
Heterografts
Melanoma
Neoplasms
2006
19 Citations (Scopus)

Porcine endothelial cells and iliac arteries transduced with AdenoIL-4 are intrinsically protected, through Akt activation, against immediate injury caused by human complement

Black, S. M., Grehan, J. F., Rivard, A. L., Benson, B. A., Wahner Hendrickson, A. E., Koch, A. E., Levay-Young, B. K. & Dalmasso, A. P., Nov 15 2006, In : Journal of Immunology. 177, 10, p. 7355-7363 9 p.

Research output: Contribution to journalArticle

Iliac Artery
Interleukin-4
Swine
Endothelial Cells
Wounds and Injuries
2004
10 Citations (Scopus)

Progression of chronic myeloid leukemia to blast crisis during treatment with imatinib mesylate

Xu, Y., Wahner Hendrickson, A. E. & Nguyen, P. L., Sep 2004, In : Archives of Pathology and Laboratory Medicine. 128, 9, p. 980-985 6 p.

Research output: Contribution to journalArticle

Blast Crisis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Cytogenetics
Bone Marrow
Clonal Evolution
2001
17 Citations (Scopus)

Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivo

Wallace, P. K., Kaufman, P. A., Lewis, L. D., Keler, T., Givan, A. L., Fisher, J. L., Waugh, M. G., Wahner Hendrickson, A. E., Guyre, P. M., Fanger, M. W. & Ernstoff, M. S., Feb 1 2001, In : Journal of Immunological Methods. 248, 1-2, p. 167-182 16 p.

Research output: Contribution to journalArticle

Bispecific Antibodies
Myeloid Cells
Phagocytosis
Interferons
Monocytes
2000
205 Citations (Scopus)

Human monocytes express CD163, which is upregulated by IL-10 and identical to p155

Sulahian, T. H., Högger, P., Wahner Hendrickson, A. E., Wardwell, K., Goulding, N. J., Sorg, C., Droste, A., Stehling, M., Wallace, P. K., Morganelli, P. M. & Guyre, P. M., 2000, In : Cytokine. 12, 9, p. 1312-1321 10 p.

Research output: Contribution to journalArticle

Interleukin-10
Glucocorticoids
Monocytes
Macrophages
Scavenger Receptors
1998
106 Citations (Scopus)

The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis

Wagner, U. G., Kurtin, P. J., Wahner Hendrickson, A. E., Brackertz, M., Berry, D. J., Goronzy, J. J. & Weyand, C. M., Dec 1 1998, In : Journal of Immunology. 161, 11, p. 6390-6397 8 p.

Research output: Contribution to journalArticle

CD40 Ligand
Germinal Center
Synovitis
Follicular Dendritic Cells
T-Lymphocytes